Development of a disease activity index for the assessment of reactive arthritis (DAREA)
| Autor: | Gérard Eberl, H Hitzelhammer, Josef S. Smolen, F Gschnait, A Studnicka-Benke |
|---|---|
| Přispěvatelé: | Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Hugot, Bérengère |
| Jazyk: | angličtina |
| Rok vydání: | 2000 |
| Předmět: |
Male
Index (economics) MESH: Pain Measurement Test validity Severity of Illness Index 0302 clinical medicine Medicine Pharmacology (medical) Prospective Studies 030212 general & internal medicine Pain Measurement MESH: Treatment Outcome MESH: Aged MESH: Middle Aged Bacterial Infections Middle Aged Anti-Bacterial Agents MESH: Reproducibility of Results MESH: Joints C-Reactive Protein Treatment Outcome [SDV.IMM]Life Sciences [q-bio]/Immunology Female Adult medicine.medical_specialty Composite score [SDV.IMM] Life Sciences [q-bio]/Immunology MESH: Bacterial Infections Validation test Arthritis Reactive Disease activity 03 medical and health sciences MESH: Cross-Sectional Studies Rheumatology MESH: Severity of Illness Index MESH: Anti-Bacterial Agents Prohibitins MESH: C-Reactive Protein Humans In patient Reactive arthritis Aged 030203 arthritis & rheumatology Measurement method MESH: Humans business.industry MESH: Arthritis Reactive Reproducibility of Results MESH: Adult medicine.disease MESH: Male MESH: Prospective Studies Cross-Sectional Studies Physical therapy Joints business MESH: Female |
| Zdroj: | Rheumatology Rheumatology, Oxford University Press (OUP), 2000, pp.148-55 |
| ISSN: | 1462-0324 1460-2172 |
| Popis: | The objectives of this study were to investigate and validate individual variables and to develop a composite score for disease activity measurement in patients with reactive arthritis (REA). In the first cross-sectional part, the clinical and laboratory evaluation of 45 patients was used to elaborate the most important individual disease activity measures. In the second prospective part, these variables as well as a composite score for disease activity measurement of REA were prospectively validated in 23 patients at two points in time. The following variables emerged as the most useful for the composite measure: number of swollen and tender joints, patient's pain and global assessment, and C-reactive protein. The score was calculated by simple addition of the individual figures. DAREA constitutes a reliable score which can easily be assessed on a day-to-day office work basis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|